Pall buys Gelman in stock swap:
This article was originally published in Clinica
Pall will acquire the manufacturer of microfiltration products, Gelman Sciences, for $33 a share in a stock swap. The deal is subject to the approval of Gelman shareholders. Gelman had previously signed an agreement to merge with another company, Memtec. This transaction was terminated by Gelman's board when it concluded that the Pall deal was more favourable to Gelman's shareholders.